Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


New processes identified for killing cancer cells

New processes identified for killing cancer cells

Media Release
University of Auckland
22 May 2014

New processes identified for killing cancer cells

The cell processes used by a traditional Asian health food supplement to inhibit the growth of prostate cancer cells, have been discovered by a University of Auckland researcher.

The research by Masters student, Ben Kao, involved comparing the impact of different ethanol and water based extracts of Ganoderma lucidium on cell lines of prostate cancer, and identifying how this compound kills cancer cells and reduces inflammation.

Ganoderma is a genus of the polypore mushrooms which grow on wood and include about 80 species, many from tropical regions. They are often referred to as shelf mushrooms or bracket fungi.

Genes associated with cell proliferation, cell cycle, and apoptosis (the process of cell death), were found by Ben, to have significant changes in their expression levels after treatment with the extracts.

The mushroom, Ganoderma lucidium or Lingzhi as it is known in China (Reishi in Japan), is widely available in Asian countries and has been used for millennia in Chinese medicine to promote good health.

They are available in Asia in a variety of forms and strengths, from low-strength pills to high quality red mushroom extract. The strength of the Ganoderma product can depend on how it is extracted and treated. Claims often made about Ganoderma lucidium are that the product will boost the immune system, improve circulation, reduce cholesterol, lower blood pressure, destroy tumours, and slow aging.

Research student, Ben Kao has had two scientific papers published recently on Ganoderma lucidium and its anti-cancer properties. The first published last year, was a literature review on the anti-cancer properties of Ganoderma lucidium – its active ingredients and pathways of activity.

This month, he has published a study comparing the gene expression profiles and pathway networks after treating prostate cancer cell lines with the different Ganoderma lucidium extracts.

“Ganoderma lucidium has been seen to have a growth inhibitory effect on prostate cancer, but most of the research has tested only one type of extract,” says Ben. “For this study we compared four different extraction methods to see which is the most powerful and to see how it exerts its effects.”

Two extracts were made using ethanol based extraction and two used water based extraction methods.

“The ethanol based extracts had the more direct effect on cancer cell growth by inhibiting the cell cycle and were more powerful than water based extracts,” says Ben. “For the water based extracts, the mechanism of action involved the immune and anti-inflammatory pathways within the cell.”

The Ganoderma lucidium was shown to have a strong effect on limiting cell growth in the cancer cell lines and has no negative effect on normal cell lines.

This study was completed for Ben’s Master’s thesis in the Discipline of Nutrition and the Auckland Cancer Society Research Centre at the University of Auckland, and supervised by ACSRC research fellow, Dr Karen Bishop. He has submitted a preliminary PhD proposal to continue with research on Ganoderma lucidium and this will focus on the impact of extracts in more advanced biological models.

For more details of the published study go to this link.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Fonterra: Canpac Site 'Resize' To Focus More On Paediatrics

Fonterra is looking at realigning its packing operations at Canpac, in the Waikato, to focus more on paediatric nutritionals... The proposed changes could mean around 110 roles may not be required at the site which currently employs 330. More>>

Warming: Warming Signs From State Of Climate Report

Climate data from air, land, sea and ice in 2013 'reflect trends of a warming planet' -- says the latest State of the Climate report, launched by U.S. and New Zealand scientists. More>>

ALSO:

Scoop Business: Embrace Falling Home Affordability, Says NZIER

Despair over the inability to afford a house is misplaced and should be embraced as an opportunity to invest in more wealth-creating activity, says the principal economist at the New Zealand Institute of Economic Research, Shamubeel Eaqub. More>>

Productivity Commission: NZ Regulation Not Keeping Pace

New Zealand regulators often have to work with out-of-date legislation, quality checks are under strain, and regulatory workers need better training and development. More>>

ALSO:

Callaghan Innovation: Investment To Help Deepen Innovation Reporting

Callaghan Innovation, the government’s high tech HQ for Kiwi business, is to help deepen New Zealand media coverage of the commercialisation of innovation through an arms-length partnership with independent business news service BusinessDesk. More>>

ALSO:

Tax Credits, Grants: Greens $1Bn R&D Plan

In the Party’s headline economic announcement, the Greens have launched their plan to build a smarter, more innovative economy which has as its centrepiece an additional $1 billion of government investment in research and development (R&D) above current spend, including tax breaks for business. More>>

ALSO:

Inflation: CPI Increases 0.3 Percent In June Quarter

The consumers price index (CPI) rose 0.3 percent in the June 2014 quarter, Statistics New Zealand said today. This follows rises of 0.3 percent the March quarter and 0.1 percent in the December 2013 quarter. More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news